SCHEMBL10412136

SCHEMBL10412136

O=C(Nc1ccccc1CCc1ccc(Cl)c(Cl)c1)C1=C(O)c2ccccc2SC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 1/20 0.43
▸ MAPT P10636 5/20 0.43
▸ POLB P06746 1/20 0.43
▸ SLC16A3 O15427 1/20 0.40
▸ PARP14 Q460N5 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ BLM P54132 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ LIPG Q9Y5X9 5/20 0.39
▸ TRPV1 Q8NER1 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ SSTR3 P32745 1/20 0.37
▸ ABCB1 P08183 1/20 0.37
▸ KCNQ2 O43526 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ MCOLN3 Q8TDD5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10412944 0.88 NR1H3 (0.42) MAPTPOLBTP53ABCB1SMN1; SMN2
SCHEMBL10412526 0.86 PTGES (0.48) PTGESMAPTPOLBMEN1RECQL
SCHEMBL10483445 0.84 MAPT (0.48) MAPTPOLBPARP14MEN1KMT2A
SCHEMBL10411377 0.83 PTGES (0.52) PTGESMAPTMEN1RECQLBLM
SCHEMBL10412040 0.81 MAPT (0.45) PTGESMAPTPOLBMEN1KMT2A
SCHEMBL10412132 0.79 PTGES (0.48) PTGESMAPTPOLBMEN1RECQL
SCHEMBL10411375 0.78 NR1H3 (0.40) MAPTPOLBTP53ABCB1SMN1; SMN2
SCHEMBL10411293 0.78 PTGES (0.42) PTGESMAPTPOLBMEN1KMT2A
SCHEMBL10412130 0.74 ALOX15 (0.56) PTGESMAPTTP53
SCHEMBL10412146 0.74 ALOX15 (0.44) PTGESMAPTMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US claimed
US-4921871-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1990-05-01 — — US disclosed
US-4874758-A LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-10-17 — — US disclosed
US-4868200-A LEUKOTRIENES, LIPOXYGENASE INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868195-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868205-A ANTIALLERGENS, ANTIINFLAMMATORY, CARDIOVASCULAR DISORDERS WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4868199-A ENZYME INHIBITORS, ANTIALLERGEN, ASTHMA, CARDIOVASCULAR, ANTIINFLAMMATORY WARNER-LAMBERT COMPANY (US) 1989-09-19 — — US disclosed
US-4761424-A Enolamides, pharmaceutical compositions and methods for treating inflammation WARNER-LAMBERT COMPANY (US) 1988-08-02 — — US disclosed
EP-0221345-A1 Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade WARNER-LAMBERT COMPANY (US) 1987-05-13 — — EP disclosed
Send feedback